Peter Vandenabeele
Scientist
Peter Vandenabeele Lab
Flanders Interuniversity Institute for Biotechnology
Belgium
Biography
hD: Ghent University, Belgium, 1990 VIB Group leader since 1996
Research Interest
Inflammation and immunity, Cancer, Proteomics
Publications
-
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice Vanden Berghe T, Hulpiau P, Martens L, Vandenbroucke R, Van Wonterghem E, Perry S, Bruggeman I, Divert T, Choi S, Vuylsteke M, Shestopalov V, Libert C, Vandenabeele P IMMUNITY, 43, 200-9, 2015
-
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity Aaes T Kaczmarek A Delvaeye T De Craene B De Koker S Heyndrickx L Delrue I Taminau J Wiernicki B De Groote P Garg A Leybaert L Grooten J Bertrand M Agostinis P Berx G Declercq W Vandenabeele P* Krysko D* Cell Reports, 15, 274-287, 2016
-
Elevated DeltaNp63alpha Levels Facilitate Epidermal and Biliary Oncogenic Transformation Devos M, Gilbert B, Denecker G, Leurs K, McGuire C, Lemeire K, Hochepied T, Vuylsteke M, Lambert J, Van Den Broecke C, Libbrecht L, Haigh J, Berx G, Lippens S, Vandenabeele P, Declercq W JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137, 494-505, 2017